Literature DB >> 1889805

Analysis of a dystrophin gene deletion by amplification of mRNA isolated from DMD myotubes cultured in vitro.

J Ehrenpreis1, M Hillers, B Junkes, M Pfordt, E Schwinger, H P Vosberg.   

Abstract

The most frequent causes for the X-linked muscular dystrophy of the allelic Duchenne (DMD) or Becker (BMD) type are partial deletions of the dystrophin gene. These mutations are accompanied either by disrupted or by preserved translational reading frames in mRNAs derived from the deleted genes. As a rule, the reading frame is destroyed in the more severe DMD, whereas it is preserved in the less severe BMD (M. Koenig et al., 1989, Am. J. Hum. Genet. 45, 498-506). We have analyzed in detail a deletion that was detected in a fetus at risk of DMD. The analysis of this mutation included the delineation of the altered subregion in the dystrophin mRNA. mRNA was isolated from myotubes derived from embryonic DMD myoblasts propagated in vitro. This study was based on enzymatic amplification by the polymerase chain reaction (PCR) of dystrophin mRNA and direct sequencing of the amplified cDNA. Exons 47 to 50 were found to be missing in the mRNA. The splicing of exon 46 to exon 51 resulted in a reading frameshift, indicating that this mutation is likely to be responsible for a DMD type of dystrophy. The clinical diagnosis of DMD for a 10-year-old patient in this family was compatible with the "reading frame" assumption.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1889805     DOI: 10.1016/0888-7543(91)90435-h

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  3 in total

Review 1.  Treatment of human disease by adeno-associated viral gene transfer.

Authors:  Kenneth H Warrington; Roland W Herzog
Journal:  Hum Genet       Date:  2006-04-13       Impact factor: 4.132

2.  Active and inactive genes localize preferentially in the periphery of chromosome territories.

Authors:  A Kurz; S Lampel; J E Nickolenko; J Bradl; A Benner; R M Zirbel; T Cremer; P Lichter
Journal:  J Cell Biol       Date:  1996-12       Impact factor: 10.539

3.  Alternative splicing of dystrophin mRNA complicates carrier determination: report of a DMD family.

Authors:  U Lenk; S Demuth; U Kräft; R Hanke; A Speer
Journal:  J Med Genet       Date:  1993-03       Impact factor: 6.318

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.